Skip to main content
Equibles
RXST logo

RXST · RxSight, Inc. · Metrics

Track RXST — free

Use RXST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RXST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.77 -0.13 (-2.65%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$201.73M
Shares
41.59M
Volume · Oct 28 291.44K Avg daily vol (3M) 790.68K

RXST metrics

86 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.90
Market cap
$201.73M

Price action

20 metrics
Price change (1W)
+0.4%
Price change (30D)
+4.9%
Price change (3M)
-19.0%
Price change (6M)
-31.7%
Price change (YTD)
-53.0%
Price change (1Y)
-43.4%
Trailing year
Price change (5Y)
-59.1%
52-week high
$13.09
52-week low
$4.51
Change from 52-week high
-62.6%
Change from 52-week low
+8.6%
Annualized volatility
62.6%
Annualized volatility (3M)
51.8%
Beta
1.1
RSI (14D)
47.3
Price vs SMA 50
-10.4%
Price vs SMA 200
-23.9%
Avg volume (3M)
790,678
Relative volume
0.7
Average dollar volume
$4.55M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
41.59M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.6×
reciprocal yield 62.2%
P / book
0.8
reciprocal yield 128.4%
FCF yield
-13.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-22.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
12.4×
reciprocal yield 8.0%
EV / revenue historical average (5Y)
12.4×
reciprocal yield 8.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
77.5%
Operating margin
-43.2%
Trailing 12 months
Net margin
-36.8%
Gross profit (TTM)
$98.87M
Operating profit (TTM)
−$55.11M
Net income (TTM)
−$46.95M
Trailing 12 months
Diluted EPS (TTM)
$-1.13
FCF margin
-21.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.09
Gross profit per diluted share (TTM)
$2.40
Operating profit per diluted share (TTM)
$-1.34
EBITDA per diluted share (TTM)
$-1.25
Net income per diluted share (TTM)
$-1.14
Operating cash flow per diluted share (TTM)
$-0.55
Free cash flow per diluted share (TTM)
$-0.66
Capital expenditures per diluted share (TTM)
$0.11
R&D per diluted share (TTM)
$0.89
Stock compensation per diluted share (TTM)
$0.76
Book value per share
$6.68

Growth

11 metrics
Revenue growth YoY
+0.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$127.58M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.8%
Year over year · more shares
Revenue CAGR (3Y)
+40.0%
Revenue CAGR (5Y)
+55.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-17.8%
Return on assets
-13.3%
Debt / equity
—
Current ratio
4.1
EBITDA (TTM)
−$51.58M
Free cash flow (TTM)
−$27.16M
Quick ratio
3.6
Interest coverage
-3,936.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$13.35M
Total assets
$352.70M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$22.73M
Capital expenditures (TTM)
$4.43M
R&D (TTM)
$36.67M
SG&A (TTM)
$117.31M
Stock compensation (TTM)
$31.34M
R&D / revenue
28.7%
Stock compensation / revenue
24.6%

Ownership (13F)

9 metrics
13F filers
151
13F filer change QoQ
-13
Institutional ownership
99.7%
Conviction holders (share of 13F filers)
0.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1.2%
Holder tenure
9.8
Price vs estimated holder cost
-65.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.3%

Short interest

3 metrics
Short interest
9.9%
Latest settlement · 6.1 days to cover
Days to cover
6.1d
Short-squeeze score
79 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$117,951
Insider-sentiment score
30 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1111485 CUSIP 78349D107 13F (30d) 17 filings 17 filers Visit website Investor relations